Gleron Tablet 90 mg contains Ticagrelor, a potent antiplatelet agent designed to prevent blood clots in patients at risk of cardiovascular events. Ticagrelor belongs to the class of P2Y12 receptor inhibitors, which work by reducing platelet aggregation, thereby lowering the risk of heart attack, stroke, and complications in patients with acute coronary syndromes. This makes Gleron an essential therapy for patients requiring long-term cardiovascular protection.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Gleron Tablet 90 mg is indicated for:
Acute coronary syndrome (ACS) – Including unstable angina and non-ST elevation myocardial infarction (NSTEMI).
ST-elevation myocardial infarction (STEMI) – As part of dual antiplatelet therapy to prevent recurrent cardiovascular events.
Prevention of thrombotic events – In patients with a history of heart attack or high risk of blood clots.
Percutaneous coronary intervention (PCI) – To reduce the risk of stent thrombosis following coronary procedures.
Ticagrelor, the active ingredient, selectively inhibits the P2Y12 receptor on platelets. By blocking this receptor, it prevents adenosine diphosphate (ADP)-mediated platelet activation and aggregation, which are key processes in clot formation. Unlike some other antiplatelet agents, Ticagrelor acts reversibly, allowing for more flexible management in case of surgical interventions or bleeding complications.
The usual recommended dose is 90 mg twice daily, taken with or without food.
It is often prescribed alongside low-dose aspirin for dual antiplatelet therapy, unless contraindicated.
Consistency in dosing is essential for optimal efficacy and to maintain cardiovascular protection.
Do not stop taking Gleron without consulting a healthcare professional, as sudden discontinuation may increase the risk of thrombotic events.
Bleeding risk: Use with caution in patients with active bleeding or a history of hemorrhagic disorders.
Liver impairment: Dose adjustments may be necessary for patients with moderate liver dysfunction; not recommended in severe cases.
Surgery: Notify your physician before any surgical procedure due to increased bleeding risk.
Drug interactions: Caution when combined with anticoagulants or other antiplatelet medications.
Common side effects of Gleron Tablet 90 mg include:
Shortness of breath (dyspnea)
Easy bruising or bleeding
Headache or dizziness
Nausea or gastrointestinal discomfort
Serious adverse effects, though less common, such as severe bleeding, should prompt immediate medical attention.
Store Gleron Tablet 90 mg in a cool, dry place at 25°C or below, protected from light and moisture. Keep out of reach of children.
Gleron Tablet 90 mg by SK Pharma is a reliable antiplatelet therapy that reduces the risk of blood clot formation and cardiovascular events in patients with heart disease or at high risk of thrombotic complications. With proper medical supervision, adherence to dosing, and lifestyle management, Gleron ensures effective cardiovascular protection while minimizing risks.
Login Or Registerto submit your questions to seller
No none asked to seller yet